JP2016501261A - マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 - Google Patents
マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 Download PDFInfo
- Publication number
- JP2016501261A JP2016501261A JP2015546419A JP2015546419A JP2016501261A JP 2016501261 A JP2016501261 A JP 2016501261A JP 2015546419 A JP2015546419 A JP 2015546419A JP 2015546419 A JP2015546419 A JP 2015546419A JP 2016501261 A JP2016501261 A JP 2016501261A
- Authority
- JP
- Japan
- Prior art keywords
- ppi
- dendrimer
- mal
- iii
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(C(C(C1)C1(C*1C=CC1C)OC)C1OCCC1)*1C(C)C1 Chemical compound CC(C(C(C1)C1(C*1C=CC1C)OC)C1OCCC1)*1C(C)C1 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/002—Dendritic macromolecules
- C08G83/003—Dendrimers
- C08G83/004—After treatment of dendrimers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL401936A PL234888B1 (pl) | 2012-12-06 | 2012-12-06 | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
| PLP-401936 | 2012-12-06 | ||
| PCT/PL2013/000163 WO2014088435A1 (en) | 2012-12-06 | 2013-12-06 | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-os-mal-iii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016501261A true JP2016501261A (ja) | 2016-01-18 |
| JP2016501261A5 JP2016501261A5 (cg-RX-API-DMAC10.html) | 2017-01-26 |
Family
ID=49955472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015546419A Pending JP2016501261A (ja) | 2012-12-06 | 2013-12-06 | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9877985B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2928479A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2016501261A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20150093216A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2013356793A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2893973A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL239144A0 (cg-RX-API-DMAC10.html) |
| PL (1) | PL234888B1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2014088435A1 (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016501260A (ja) * | 2012-12-06 | 2016-01-18 | ウニヴェルシテット・ウズキUniwersytet Lodzki | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL416636A1 (pl) * | 2016-03-24 | 2017-09-25 | Univ Łódzki | Medyczne zastosowanie dendrymeru polipropylenoiminowego czwartej generacji, opłaszczonego maltotriozą |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016501260A (ja) * | 2012-12-06 | 2016-01-18 | ウニヴェルシテット・ウズキUniwersytet Lodzki | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090208580A1 (en) | 2005-09-19 | 2009-08-20 | Regents Of The University Of Michigan | Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles |
| US20110177602A1 (en) * | 2007-06-27 | 2011-07-21 | Endress + Hauser Conducts Gesellschaft furMess-und Regeltechnik mbH +Co. KG | Composite Structure |
-
2012
- 2012-12-06 PL PL401936A patent/PL234888B1/pl unknown
-
2013
- 2013-12-06 CA CA2893973A patent/CA2893973A1/en not_active Abandoned
- 2013-12-06 EP EP13821004.2A patent/EP2928479A1/en not_active Withdrawn
- 2013-12-06 KR KR1020157018094A patent/KR20150093216A/ko not_active Withdrawn
- 2013-12-06 US US14/650,521 patent/US9877985B2/en not_active Expired - Fee Related
- 2013-12-06 JP JP2015546419A patent/JP2016501261A/ja active Pending
- 2013-12-06 AU AU2013356793A patent/AU2013356793A1/en not_active Abandoned
- 2013-12-06 WO PCT/PL2013/000163 patent/WO2014088435A1/en not_active Ceased
-
2015
- 2015-06-02 IL IL239144A patent/IL239144A0/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016501260A (ja) * | 2012-12-06 | 2016-01-18 | ウニヴェルシテット・ウズキUniwersytet Lodzki | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用 |
Non-Patent Citations (4)
| Title |
|---|
| A. JANASZEWSKA, NEW JOURNAL OF CHEMISTRY, vol. V36 N2, JPN5016000505, 1 January 2012 (2012-01-01), pages 428 - 437, ISSN: 0003754517 * |
| BARBARA ZIEMBA, BIOPOLYMERS, vol. V97 N8, JPN5016000507, 17 August 2012 (2012-08-17), pages 642 - 648, ISSN: 0003609151 * |
| BARBARA ZIEMBA: "INFLUENCE OF FOURTH GENERATION POLY (PROPYLENEIMINE) DENDRIMERS ON BLOOD CELLS", JOURNAL OF BIOMEDICAL METERIALS RESEARCH PART A, vol. V100A N11, JPN5016000506, 24 November 2012 (2012-11-24), pages 2870 - 2880, ISSN: 0003754518 * |
| FRANIAK-PIETRYGA IDA, BLOOD, vol. V120 N21, JPN5016000504, 16 November 2012 (2012-11-16), ISSN: 0003609148 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016501260A (ja) * | 2012-12-06 | 2016-01-18 | ウニヴェルシテット・ウズキUniwersytet Lodzki | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150093216A (ko) | 2015-08-17 |
| AU2013356793A1 (en) | 2015-07-23 |
| PL234888B1 (pl) | 2020-04-30 |
| CA2893973A1 (en) | 2014-06-12 |
| WO2014088435A1 (en) | 2014-06-12 |
| PL401936A1 (pl) | 2014-06-09 |
| US20150306134A1 (en) | 2015-10-29 |
| EP2928479A1 (en) | 2015-10-14 |
| US9877985B2 (en) | 2018-01-30 |
| IL239144A0 (en) | 2015-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nooshabadi et al. | Impact of atorvastatin loaded exosome as an anti-glioblastoma carrier to induce apoptosis of U87 cancer cells in 3D culture model | |
| Gravelle et al. | Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma | |
| Franiak-Pietryga et al. | The influence of maltotriose-modified poly (propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI | |
| WO2019126739A1 (en) | Pyrvinium pamoate anti-cancer therapies | |
| Holwell et al. | Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model | |
| JP2025063161A (ja) | ルテリアル、並びにその分離および培養方法 | |
| Lan et al. | Exosomal microRNAs: an emerging important regulator in acute lung injury | |
| Chen et al. | Bufotalin loaded biomimetic nanodrug for combined chemo/photodynamic therapy of cancer | |
| Pidala et al. | Ixazomib for treatment of refractory chronic graft-versus-host disease: a chronic GVHD consortium phase II trial | |
| Ünsal et al. | The apoptotic effect of garlic (Allium sativum) derived SEVs on different types of cancer cell lines in vitro | |
| Peng et al. | Disrupting calcium homeostasis and glycometabolism in engineered lipid-based pharmaceuticals propel cancer immunogenic death | |
| Benvenuto et al. | Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo | |
| CN109745326B (zh) | 一种包含吉非替尼和组蛋白去乙酰酶抑制剂的药物组合物,其脂质体制剂及其制药用途 | |
| KR20200055722A (ko) | 약물 내성 신경아교종의 치료 | |
| US9877985B2 (en) | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer PPI-G4-OS-MAL-III | |
| Zhu et al. | A hierarchically acidity-unlocking nanoSTING stimulant enables cascaded STING activation for potent innate and adaptive antitumor immunity | |
| JP2016501260A (ja) | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用 | |
| EP2285420A2 (en) | Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer | |
| US10022395B2 (en) | Application of maltotriose-coated 4th generation poly(propyleneimine) dendrimer PPI-G4-OS-Mal-III | |
| Abdulmalek et al. | Thymoquinone-conjugated liposomes improve cytotoxic and proapoptotic effects against hepatocellular cancer by altering the EGFR/ERK/MEK signaling axis | |
| WO2020171138A1 (ja) | 放射線治療による抗腫瘍免疫効果を評価する末梢血バイオマーカー | |
| CN116785256A (zh) | 一种可诱导细胞免疫性死亡的纳米颗粒材料及其制备方法和应用 | |
| Huang et al. | Preparation and biocompatibility evaluation of PEG-PLL/RGD-PEG-DSPE/Phospholipid/CaP nanoparticles | |
| RU2810558C1 (ru) | Способ подбора лекарственных средств для реализации фармакологической индукции митохондриальной дисфункции в макрофагах для противоопухолевой терапии | |
| WO2017163124A2 (en) | Medical use of poly(propylene imine) glycodendrimers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20160218 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161205 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161205 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170801 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20171031 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20171227 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180201 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20180313 |